Expression and purification of bioactive high-purity recombinant mouse SPP1 in Escherichia coli. (Q54292422)

27 May 2018

title

Expression and purification of bioactive high-purity recombinant mouse SPP1 in Escherichia coli. (English)

1 reference

27 May 2018

1 reference

Yunsheng Yuan

1

1 reference

27 May 2018

Xiyuan Zhang

2

1 reference

27 May 2018

Shunyan Weng

3

1 reference

27 May 2018

Wen Guan

4

1 reference

27 May 2018

Di Xiang

5

1 reference

27 May 2018

Jin Gao

6

1 reference

27 May 2018

Jingjing Li

7

1 reference

27 May 2018

Wei Han

8

1 reference

27 May 2018

Yan Yu

9

1 reference

27 May 2018

publication date

25 March 2014

1 reference

27 May 2018

Applied Biochemistry and Biotechnology

published in

1 reference

27 May 2018

volume

173

1 reference

27 May 2018

issue

2

1 reference

27 May 2018

page(s)

421-432

1 reference

27 May 2018

https://scigraph.springernature.com/pub.10.1007/s12010-014-0849-7

exact match

0 references

cites work

Osteopontin: role in cell signaling and cancer progression

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-0849-7

Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-0849-7

Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-0849-7

Osteopontin protects against cardiac ischemia-reperfusion injury through late preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-0849-7

Milk osteopontin, a nutritional approach to prevent alcohol-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-0849-7

Osteopontin is involved in estrogen-mediated protection against diethylnitrosamine-induced liver injury in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-0849-7

Streptozotocin (STZ) mediates acute upregulation of serum and pancreatic osteopontin (OPN): a novel islet-protective effect of OPN through inhibition of STZ-induced nitric oxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-0849-7

Osteopontin expression is associated with improved survival in patients with pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-0849-7

Osteopontin--a molecule for all seasons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-0849-7

Expression and characterization of recombinant osteopontin peptides representing matrix metalloproteinase proteolytic fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-0849-7

Osteopontin is cleaved at multiple sites close to its integrin-binding motifs in milk and is a novel substrate for plasmin and cathepsin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-0849-7

Post-translational modification and proteolytic processing of urinary osteopontin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-0849-7

In vitro phosphorylation of mouse osteopontin expressed in E. coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-0849-7

Improved cellular response of osteoblast cells using recombinant human osteopontin protein produced by Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-0849-7

Expression and purification of bioactive high-purity mouse monokine induced by IFN-gamma in Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-0849-7

Expressions and purification of a mature form of recombinant human Chemerin in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-0849-7

Upregulation of osteopontin by osteocytes deprived of mechanical loading or oxygen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-0849-7

Functional characterization of stromal osteopontin in melanoma progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-0849-7

The polymorphisms of osteopontin gene and plasma osteopontin protein levels with susceptibility to colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-0849-7

Plasma osteopontin is a useful diagnostic biomarker for advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-0849-7

Nasal administration of recombinant osteopontin attenuates early brain injury after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-0849-7

Effects of recombinant osteopontin on blood-brain barrier disruption after subarachnoid hemorrhage in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-0849-7

Mechanisms of osteopontin-induced stabilization of blood-brain barrier disruption after subarachnoid hemorrhage in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-0849-7

Effect of bone-marrow-derived mesenchymal stem cells on high-potential hepatocellular carcinoma in mouse models: an intervention study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-0849-7

10.1007/S12010-014-0849-7

21 January 2018

Identifiers

DOI

1 reference

27 May 2018

1 reference

27 May 2018